Broad-Spectrum Antibiotic Regimen Affects Survival in Patients Receiving Nivolumab for Non-Small Cell Lung Cancer

Antibiotic-induced dysbiosis may affect the efficacy of immune checkpoint inhibitors. We investigated the impact of antibiotics on the clinical outcomes of nivolumab in patients with non-small cell lung cancer (NSCLC). Patients who received nivolumab for NSCLC between July 2015 and June 2018 and who...

Descripción completa

Detalles Bibliográficos
Autores principales: Geum, Min Jung, Kim, Chungsoo, Kang, Ji Eun, Choi, Jae Hee, Kim, Jae Song, Son, Eun Sun, Lim, Sun Min, Rhie, Sandy Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151442/
https://www.ncbi.nlm.nih.gov/pubmed/34066877
http://dx.doi.org/10.3390/ph14050445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151442/
https://www.ncbi.nlm.nih.gov/pubmed/34066877
http://dx.doi.org/10.3390/ph14050445

Ejemplares similares